Table 2. HSPC111/nuclear YAP1 expression and clinicopathological variables in GC patients.
| HSPC111 (+)/ Nuclear YAP1 (+) | HSPC111 (+)/ Nuclear YAP1 (−) | HSPC111 (−)/ Nuclear YAP1 (+) | HSPC111 (−)/ Nuclear YAP1 (−) | P value | ||
|---|---|---|---|---|---|---|
| Variables | Number | n (29) | n (19) | n (29) | n (43) | |
| Gender | 0.828 | |||||
| Male | 86 | 21 | 15 | 21 | 29 | |
| Female | 34 | 8 | 4 | 8 | 14 | |
| Age* | 0.291 | |||||
| >57.5 | 60 | 13 | 9 | 19 | 19 | |
| <57.5 | 60 | 16 | 10 | 10 | 24 | |
| Depth of invasion | 0.232 | |||||
| T1/2 | 38 | 5 | 8 | 11 | 14 | |
| T3/4 | 82 | 24 | 11 | 18 | 29 | |
| LNM | 0.035 | |||||
| Yes | 48 | 7 | 7 | 12 | 22 | |
| No | 72 | 22 | 12 | 17 | 21 | |
| Tumor size | 0.127 | |||||
| < 6cm | 101 | 23 | 19 | 22 | 37 | |
| > = 6cm | 19 | 6 | 0 | 7 | 6 | |
| Differentiation | 0.126 | |||||
| Low/undifferentiated | 86 | 22 | 17 | 17 | 30 | |
| High/moderate | 34 | 7 | 2 | 12 | 13 | |
| TNM stage | 0.376 | |||||
| I/II | 55 | 10 | 10 | 12 | 23 | |
| III | 65 | 19 | 9 | 17 | 20 |
(n = 120).
Age* = mean age; LNM = lymph node metastasis.